Swiss-Cheese Model Kausalitas Efek Samping Obat: Laporan Kasus Perdarahan Saluran Cerna Pada Penggunaan Obat Herbal
Abstract
Abstract—Pharmacovigilance is a process to identify, evaluating, comprehending, and avoiding harmful drug or treatment-related events. Unfortunately, Indonesia still has a relatively low rate of reporting adverse drug reactions (ADR), including those caused by herbal medications. Lack of information is one factor contributing to this, among others being ignorance and lack of awareness. The Swiss-cheese model is a risk analysis approach that can be used to examine variables that could contribute to the occurrence of adverse drug reactions. A woman, 72, was checked into the hospital after complaining of melena. The patient had previously used herbal product that containing of Retrofracti fructus, Languatis rhizoma, Piperis nigri fructus, Blumeae folium, and Orthosiphonis folium, patient also consume herbs that made from lemongrass (Cymbopogon citratus) dan turmeric (Curcuma longa). Some herbs may have an impact on the cyclooxygenase (COX) system, raising the danger of gastrointestinal problems including bleeding. Diverse patient comorbidities may potentiate adverse drug reactions, necessitating careful monitoring of medication side effects, encompassing both pharmaceutical and herbal remedies. Swiss-cheese model is an approach that can be used to analyze factors that can contribute to adverse drug event. Naranjo and WHO-UMC were used in the causality analysis.
Keywords: herbs; adverse drug reaction, gastrointestinal bleeding, patient safety, pharmacovigilans
Abstrak—Farmakovigilans merupakan kegiatan ditujukan sebagai upaya mendeteksi, menilai, memahami, dan mencegah kejadian yang merugikan akibat obat ataupun produk pengobatan. Sayangnya pelaporan efek samping obat (ESO) termasuk obat herbal masih sangat rendah di Indonesia. Hal ini dapat diakibatkan oleh kurangnya pengetahuan dan perhatian, salah satunya akibat kurangnya data. Swiss-cheese model adalah pendekatan analisis risiko yang dapat digunakan untuk menganalisis faktor-faktor yang dapat berkontribusi terhadap kejadian ESO. Seorang wanita 72 tahun masuk ke rumah sakit dengan keluhan melena. Pasien memiliki riwayat penggunaan produk herbal yang mengandung Retrofracti fructus, Languatis rhizoma, Piperis nigri fructus, Blumeae folium, Orthosiphonis folium, serta memiliki riwayat mengonsumsi jamu serai (Cymbopogon citratus) dan kunyit (Curcuma longa). Beberapa herbal memiliki potensi mempengaruhi sistem siklooksigenase (COX), sehingga meningkatkan risiko terjadinya gangguan pada saluran cerna seperti perdarahan. Serangkaian kondisi pasien dapat meningkatkan risiko terjadinya efek samping obat, sehingga perlunya perhatian terhadap efek samping obat termasuk obat herbal. Pemodelan Swiss-cheese merupakan suatu pendekatan yang dapat digunakan untuk menganalisis faktor-faktor yang dapat berkontribusi terhadap kejadian ESO. Analisis kausalitas dilakukan dengan menggunakan WHO-UMC dan Naranjo. Hal ini ditujukan sebagai upaya peningkatan pelayanan kesehatan yang aman bagi pasien.
Kata kunci: obat herbal, efek samping, perdarahan saluran cerna, keamanan pasien, farmakovigilans
Downloads
References
World Health Organization. WHO global report on traditional and complementary medicine 2019 [Internet]. Geneva: World Health Organization; 2019 [cited 2023 Jan 18]. Available from: https://apps.who.int/iris/handle/10665/312342
Kementerian Kesehatan Republik Indonesia. Laporan Nasional Riskesdas 2018. Jakarta: Balitbangkes;
BPOM. Mekanisme Monitoring Efek Samping Obat Tradisional dan Suplemen Kesehatan. 2021.
World Health Organization. Pharmacovigilance [Internet]. [cited 2023 Jan 13]. Available from: https://www.who.int/teams/regulation-prequalification/regulation-and-safety/pharmacovigilance
Tamlicha, Litacha, Darmayani, IGAAP Sri, Marzuki, Jefman, Nego, Mario Abet. Learning from Adverse Drug Event Reporting in Indonesia 2011 – 2016: Promoting Learning Over Blame Among Doctors and Healthcare Facility (Hospital and Primary Healthcare). ISQua’s 35th Int Conf. Kuala Lumpur; 2018.
Varallo FR, Guimarães S de OP, Abjaude SAR, Mastroianni P de C. Causes for the underreporting of adverse drug events by health professionals: a systematic review. Rev Esc Enferm USP. 2014;48:739–47.
Al-Worafi YM. Herbal medicines safety issues. In: Al-Worafi Y, editor. Drug Saf Dev Ctries [Internet]. Academic Press; 2020 [cited 2023 Jan 18]. p. 163–78. Available from: https://www.sciencedirect.com/science/article/pii/B9780128198377000145
Zhang J, Onakpoya IJ, Posadzki P, Eddouks M. The Safety of Herbal Medicine: From Prejudice to Evidence. Evid Based Complement Alternat Med. 2015;2015:1–3.
DiGregorio AM, Alvey H. Gastrointestinal Bleeding. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 [cited 2023 Jan 18]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK537291/
BPOM. Cek Produk BPOM [Internet]. Cek Prod. BPOM. [cited 2023 Jan 18]. Available from: https://cekbpom.pom.go.id/
BPOM. Kriteria dan Tata Laksana Pendaftaran Obat Tradisional, Obat Herbal Terstandar dan Fitofarmaka [Internet]. 2005 [cited 2023 Jan 18]. Available from: https://sireka.pom.go.id/requirement/HK.00.05.41.1384-2005.pdf
Yastiara I, Nugraha F, Kurniawan H. Identification of Paracetamol in Jamu Using Thin Layer Chromatography Analysis Method.
Willianto HC, Wijayahadi N. Pengaruh Pemberian Ramuan Ekstrak Produk X Sebagai Analgesik Pada Mencit. J Kedokt Diponegoro. 2016;5:972–81.
Akter M, Rahman S, Afsana NA, Morshed T, Roney SI, Debnath K, et al. Evaluation of antinociceptive activity of an Indonesian herbal product Sendi in Swiss albino mice. 2013;
Qureshi O, Dua A. COX Inhibitors. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 [cited 2023 Jan 18]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK549795/
Abebe W. Review of herbal medications with the potential to cause bleeding: dental implications, and risk prediction and prevention avenues. EPMA J. 2019;10:51–64.
Abebe W. Herbal medication: potential for adverse interactions with analgesic drugs. J Clin Pharm Ther. 2002;27:391–401.
Srivastava KC, Bordia A, Verma SK. Curcumin, a major component of food spice turmeric (Curcuma longa) inhibits aggregation and alters eicosanoid metabolism in human blood platelets. Prostaglandins Leukot Essent Fatty Acids. 1995;52:223–7.
Wang Y, Yang H, Chen L, Jafari M, Tang J. Network-based modeling of herb combinations in traditional Chinese medicine. Brief Bioinform [Internet]. 2021 [cited 2023 Jan 18];22. Available from: https://doi.org/10.1093/bib/bbab106
Perneger TV. The Swiss cheese model of safety incidents: are there holes in the metaphor? BMC Health Serv Res. 2005;5:71.
Age - Related Gastric Changes. J Surg. 2016;4:20.
Tarnawski AS, Ahluwalia A, Jones MK. Increased susceptibility of aging gastric mucosa to injury: The mechanisms and clinical implications. World J Gastroenterol WJG. 2014;20:4467–82.
Vakhshoori M, Keshteli AH, Saneei P, Esmaillzadeh A, Adibi P. Relationship Between Meal Frequency and Gastroesophageal Reflux Disease (GERD) in Iranian Adults. Dig Dis Sci. 2018;63:2998–3008.
Yamamoto Y, Furukawa S, Watanabe J, Kato A, Kusumoto K, Miyake T, et al. Association Between Eating Behavior, Frequency of Meals, and Functional Dyspepsia in Young Japanese Population. J Neurogastroenterol Motil. 2022;28:418–23.
Xu J-H, Lai Y, Zhuang L-P, Huang C-Z, Li C-Q, Chen Q-K, et al. Certain Dietary Habits Contribute to the Functional Dyspepsia in South China Rural Area. Med Sci Monit Int Med J Exp Clin Res. 2017;23:3942–51.
Faigel DO, Metz DC. Prevalence, etiology, and prognostic significance of upper gastrointestinal hemorrhage in diabetic ketoacidosis. Dig Dis Sci. 1996;41:1–8.
Freeman R. Diabetic autonomic neuropathy. Handb Clin Neurol. 2014;126:63–79.
Camilleri M. Clinical practice. Diabetic gastroparesis. N Engl J Med. 2007;356:820–9.
Katz LA, Spiro HM. Gastrointestinal manifestations of diabetes. N Engl J Med. 1966;275:1350–61.
Kim J, Lee J, Shin CM, Lee DH, Park B-J. Risk of gastrointestinal bleeding and cardiovascular events due to NSAIDs in the diabetic elderly population. BMJ Open Diabetes Res Care. 2015;3:e000133.
The Joint Commission. National Patient Safety Goals [Internet]. 2022. Available from: https://www.jointcommission.org/standards/national-patient-safety-goals/-/media/131f1a35ea9743eca04b9858b73b0a93.ashx
Osanlou R, Walker L, Hughes DA, Burnside G, Pirmohamed M. Adverse drug reactions, multimorbidity and polypharmacy: a prospective analysis of 1 month of medical admissions. BMJ Open. 2022;12:e055551.
Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329:15–9.
Qing-ping S, Xiao-dong J, Feng D, Yan L, Mei-ling Y, Jin-xiu Z, et al. Consequences, measurement, and evaluation of the costs associated with adverse drug reactions among hospitalized patients in China. BMC Health Serv Res. 2014;14:73.
Hakkarainen KM, Hedna K, Petzold M, Hägg S. Percentage of Patients with Preventable Adverse Drug Reactions and Preventability of Adverse Drug Reactions – A Meta-Analysis. PLOS ONE. 2012;7:e33236.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
- Articles published in Keluwih: JKK are licensed under a Creative Commons Attribution-ShareAlike 4.0 International license. You are free to copy, transform, or redistribute articles for any lawful purpose in any medium, provided you give appropriate credit to the original author(s) and the journal, link to the license, indicate if changes were made, and redistribute any derivative work under the same license.
- Copyright on articles is retained by the respective author(s), without restrictions. A non-exclusive license is granted to Kluwih: JKK to publish the article and identify itself as its original publisher, along with the commercial right to include the article in a hardcopy issue for sale to libraries and individuals.
- By publishing in Keluwih: JKK, authors grant any third party the right to use their article to the extent provided by the Creative Commons Attribution-ShareAlike 4.0 International license.